We are mapping human aging to develop a pipeline of therapies that treat disease and extend healthy lifespan.

We are mapping human aging to develop a pipeline of therapies that treat disease and extend healthy lifespan.

We are mapping human aging to develop a pipeline of therapies that treat disease and extend healthy lifespan.

Find out more

We are a clinical- stage biotechnology company committed to a clear vision:

We are a clinical-stage biotechnology company committed to a clear vision:

We are a clinical-stage biotechnology stage committed to a clear vision:

Growing older without aging

Diseases of aging are an enormous unmet medical need

Diseases of aging are an enormous unmet medical need

Diseases of aging are an enormous unmet medical need

Aging drives many devastating illnesses, but therapies are lacking. Today’s technology enables us to translate scientific progress on aging into therapeutic development.

Now is a key moment of opportunity for longevity medicine.

Unlocking new aging targets with our human-first discovery

Unlocking new aging targets with our human- first discovery

Unlocking new aging targets with our human- first discovery

Our platform translates insights from human aging profiles into a mechanistically diverse portfolio of drugs, creating medicines that treat or prevent diseases of aging in entirely new ways.

Redefining healthy aging with longevity-focused therapeutics

Redefining healthy aging with longevity- focused therapeutics

Redefining healthy aging with longevity-focused therapeutics

We are building a broad portfolio of drugs to address acute diseases of aging.

Our medicines will expand the spectrum of treatable age-related disease, ultimately separating the process of growing older from disability and degeneration.

Left gradient Right gradient